HOME >> BIOLOGY >> NEWS
Disabling a carbohydrate trigger reduces obesity and appetite

BETHESDA, MD (August 30, 2006) Until about 15 years ago, insulin was believed primarily responsible for turning carbohydrates into fat. But then it became apparent that diet alone could stimulate glucose metabolism and fat synthesis, even when insulin levels were low or absent.

Five years ago, researchers discovered that a substance known as ChREBP (carbohydrate response element binding protein), quite independent of insulin, initiated a sequence responsible for converting excess carbohydrates to fatty acids for long-term storage.

In a study that appears in this month's edition of the American Journal of Physiology-Endocrinology and Metabolism, the same laboratory that identified ChREBP (pronounced "kreb") and its role in fat storage has discovered that the absence of ChREBP in mice keeps normally obese mice from becoming fat, lowers their blood triglycerides (a type of fat) and reduces the insulin resistance related to type 2 diabetes

The research, titled "Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice," was carried out by University of Texas researchers Katsumi Iizuka, Bonnie Miller and Kosaku Uyeda of the UT Southwestern Medical Center, in Dallas. Uyeda is also associated with the Veterans Affairs Medical Center in Dallas. The American Physiological Society published the study.

"Carbohydrates are broken down into glucose and other simple sugars by digestion," explained Uyeda, the principal investigator. "These sugars enter the bloodstream and are mostly taken up by the liver." The liver does different things with the sugars, depending upon the body's energy needs. But if the body has enough energy, with the help of ChREBP, it converts glucose into fatty acids and stores it.

"Many people believe that evolutionary pressure favored those who could convert excess carbohydrate to fat and store it because they were bet
'"/>

Contact: Christine Guilfoy
cguilfoy@the-aps.org
301-634-7253
American Physiological Society
30-Aug-2006


Page: 1 2

Related biology news :

1. Disabling a sensory organ prompts female mice to act like male mice
2. Disabling key protein may give physicians time to treat pneumonic plague
3. Disabling gene defuses rheumatoid arthritis in mice
4. Burning fat and carbohydrate during exercise
5. UGA researchers discover cell-wall carbohydrate that is crucial to anthrax bacterium
6. Loss of central vision with age may be linked to quality of dietary carbohydrates
7. Reduced calorie and carbohydrate diet slows progression of Alzheimers disease in mouse model
8. p53 gene mutations and inflammation trigger skin cancer
9. University of Pittsburgh discovers genetic shut down trigger in healthy immune cells
10. Climate change could trigger boom and bust population cycles leading to extinction
11. Glucose triggers brain cell death in rats after hypoglycemic coma

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/29/2020)... , ... January 29, 2020 , ... ... and in vitro toxicology testing solutions, has announced a record earnings year for ... weeks, INDIGO showed more than a twenty percent increase in revenue and a ...
(Date:1/27/2020)... ... 2020 , ... Cytonus Therapeutics Inc. today announced the appointment ... former senior management consultant at McKinsey & Company who holds three Harvard degrees. ... , “Chris Thorne has exceptional business acumen with a proven track record ...
(Date:1/23/2020)... ... , ... GIOSTAR/HEAMGEN has developed and secured patented ... red blood cells are made utilizing a bioreactor that permits the production of ... the need for a human blood donor. GIOSTAR/HEAMGEN mature red blood ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... 2020 , ... COBO Technologies and Cardea Bio partner to ... agreed to co-develop and market a portfolio of CRISPR QC products and services ... longer-term, the parties aim to develop a COBO branded QC device based on ...
(Date:1/10/2020)... , ... January 09, 2020 , ... ... Drug Development establishes benchmarks for the vendor qualification process, a critical element ... the process volume and complexity of the vendor qualification process creates delays in ...
(Date:1/10/2020)... ... January 09, 2020 , ... GenScript Biotech Corp., ... Biotech Global Forum on Jan. 14 in San Francisco, coinciding with the JP ... and the Booming China Market," will feature gene and cell therapy leaders in ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... helps couples and individuals grow their family, has announced that five of their ... Castle Connolly. Since 1991, the renowned publishing company Castle Connolly has ...
Breaking Biology Technology:
Cached News: